483
Novel Laboratories, Inc. d.b.a Lupin SomersetFDA 483 - Novel Laboratories, Inc. d.b.a Lupin Somerset - January 13, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Novel Laboratories, Inc. d.b.a Lupin in Somerset, NJ, was inspected and received two observations related to manufacturing practices. The inspection revealed deficiencies in laboratory controls, specifically regarding the scientific justification for microbial testing procedures, and issues with equipment qualification and design for its intended use in drug product manufacturing. These findings indicate potential risks to drug product quality and purity.
- Inspection Date
- January 13, 2023
- Product Type
- Drugs
Open in Dashboard
ID · 2dd544ba-ef47-4a02-8afc-afbe901915b8